LLVK
LLVK is a selective IκB phosphorylation inhibitor. LLVK reduces LPS-induced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) . LLVK is promising for research of inflammatory bowel disease and rheumatoid arthritis[1].
Product Specifications
CAS Number
798540-36-0
UNSPSC
12352209
Target
IKK; NF-κB
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
NCCCC[C@@H](C(O)=O)NC([C@H](C(C)C)NC([C@H](CC(C)C)NC([C@@H](N)CC(C)C)=O)=O)=O
Molecular Formula
C23H45N5O5
Molecular Weight
471.63
References & Citations
[1]Liu W, et al. Alternation in sequence features and their influence on the anti-inflammatory activity of soy peptides during digestion and absorption in different enzymatic hydrolysis conditions. Food Chem. 2025 Apr 15;471:142824.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK5F798-01 48 Test
Mouse Macrophage Stimulating Protein (MSP) ELISA Kit-Sandwich
Sign In for Pricing
View Details EK5F798-02 96 Tests
Mouse Macrophage Stimulating Protein (MSP) ELISA Kit-Sandwich
Sign In for Pricing
View Details 244726-ML405 100 µL
CLASP1 (Cytoplasmic linker Associated Protein 1, DKFZp686D1968, DKFZp686H2039, FLJ33821, FLJ41222, KIAA0622, MAST1, MGC131895) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
G1359 96 Tests
Probable Polypeptide N-acetylgalactosaminyltransferase 8 (GALNT8) Human ELISA Kit
Sign In for Pricing
View Details